House Subcommittee to Examine Prescription Drug Supply Chain

Hearing to focus on lowering healthcare costs for Americans

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

The House Subcommittee on Health of the Committee on Energy and Commerce will hold a hearing on Wednesday, February 11, 2026 to examine the prescription drug supply chain and explore ways to lower healthcare costs for Americans. Witnesses from various industry groups, including PhRMA, BIO, AAM, PCMA, HSCA, HDA, ERIC, and NCPA, as well as a law professor, will provide testimony.

Why it matters

The high cost of prescription drugs is a major concern for many Americans, and this hearing aims to identify potential solutions within the complex pharmaceutical supply chain. Lawmakers are seeking to understand the various stakeholders' perspectives on how to make healthcare more affordable.

The details

The hearing, titled "Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain", will take place at 10:15 a.m. EST in the John D. Dingell Room of the Rayburn House Office Building. Witnesses include representatives from industry groups like PhRMA, BIO, AAM, PCMA, HSCA, HDA, ERIC, and NCPA, as well as a law professor from Washington University in St. Louis.

  • The hearing will be held on Wednesday, February 11, 2026 at 10:15 a.m. EST.

The players

Lori M. Reilly

Chief Operating Officer of PhRMA.

John F. Crowley

President and CEO of Biotechnology Innovation Organization (BIO).

John Murphy

President and CEO of Association for Accessible Medicines (AAM).

David Marin

President and CEO of Pharmaceutical Care Management Association (PCMA).

Angie Boliver

President and CEO of Healthcare Supply Chain Association (HSCA).

Chester "Chip" Davis, Jr.

President and CEO of Healthcare Distribution Alliance (HDA).

James Gelfand

President and CEO of The ERISA Industry Committee (ERIC).

B. Douglas Hoey

Chief Executive Officer of National Community Pharmacists Association (NCPA).

Rachel E. Sachs

Professor of Law at Washington University in St. Louis.

Got photos? Submit your photos here. ›

The takeaway

This hearing represents a significant effort by lawmakers to address the high cost of prescription drugs and find ways to make healthcare more affordable for all Americans. By gathering input from a diverse set of stakeholders in the pharmaceutical supply chain, policymakers hope to identify potential solutions that balance the needs of patients, providers, and the industry.